Table 2.
Association between the ApoB/ApoA-Ι ratio and MACE and readmission occurrence during the follow-up period.
| End point | Category | Crude model | Model 1 | Model 2 | |||
|---|---|---|---|---|---|---|---|
| HR(95%CI) | P value | HR(95%CI) | P value | HR(95%CI) | P value | ||
| MACEs | ApoB/ApoA-Ι |
1.60 (1.13–2.27) |
0.007 |
1.65 (1.17–2.34) |
0.005 |
3.13 (1.92–5.12) |
< 0.001 |
| Low ratio |
1.0 (Reference) |
1.0 (Reference) |
1.0 (Reference) |
||||
| High ratio |
1.29 (1.01–1.65) |
0.038 |
1.31 (1.03–1.67) |
0.030 |
1.54 (1.14–2.09) |
0.005 | |
| Readmission | ApoB/ApoA-Ι |
1.43 (1.03–1.98) |
0.034 |
1.49 (1.07–2.08) |
0.018 |
2.40 (1.49–3.87) |
< 0.001 |
| Low ratio |
1.0 (Reference) |
1.0 (Reference) |
1.0 (Reference) |
||||
| High ratio |
1.23 (0.99–1.54) |
0.065 |
1.26 (1.01–1.57) |
0.045 |
1.43 (1.08–1.88) |
0.012 | |
Abbreviations: HR hazard ratio; CI confidence interval;
Crude model: unadjusted. Model 1: adjusted for age, sex. Model 2: adjusted for age, sex, TC, TG, LDL-C and HDL-C.